The UAE pharmaceutical market is anticipated to register impressive growth in the forecast period (2024-2028)
Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Furthermore, the growing government support, such as the encouragement by the Ministry of Health and Prevention for international pharmaceutical companies to transfer their production lines to the UAE, is another factor strengthening the UAE pharmaceutical market.
Growing Government Initiatives:
The rising number of initiatives by the United Arab Emirates government for the advancement of the pharmaceutical industry is expected to fuel the market's growth. The UAE pharmaceutical market is targeted by initiatives such as the Dubai Industrial Strategy 2030 and the Abu Dhabi Vision 2030 due to its potential for future growth, export potential, and medium- to long-term economic impact. Additionally, the increasing investments by the government in the research and development of pharmaceutical and therapeutic products are expected to drive the market's growth in the coming years.Rising Occurrences of Diseases:
The growing prevalence of various diseases such as cancer, diabetes, cardiovascular disorders, respiratory problems, renal disorders, among others, in the country, requires effective treatment and is expected to drive the growth of the UAE pharmaceutical market during the forecast period. For instance, according to the Global Cancer Observatory, in 2020, about 4,807 new cases of cancer were reported in the UAE. Out of these, 1,030 were breast cancer, 510 were colorectal cancer, 405 were thyroid cancer, 272 were leukemia, 270 were prostate cancer, and 2380 were other types of cancers. Furthermore, the increasing disease burden has led to a surge in the demand for pharmaceutical products, which is expected to bolster the market's growth.Market Segmentation
The UAE pharmaceutical market is segmented by drug type, product type, application, distribution channel, company, and region. Based on drug type, the market is differentiated between generic drugs and branded drugs. Based on product type, the market is divided between prescription drugs and over the counter drugs. Based on application, the market is fragmented into cardiovascular, musculoskeletal, oncology, anti-infective, metabolic disorder, and others. Based on distribution channel, the market is bifurcated into retail pharmacy, hospital pharmacy, and e-pharmacy. Based on region, the market is divided among Dubai region, Sharjah region, Abu Dhabi region and the rest of the UAE.Company Profile
Julphar Gulf Pharmaceutical Industries, Bayer Consumer Health, Lifepharma FZE, Niner Pharmaceuticals LLC, GlaxoSmithKline & Neopharma, Pfizer UAE, Johnson & Johnson Middle East FZ-LLC, among others are some of the major market players in the UAE pharmaceutical market.Report Scope
In this report, UAE pharmaceutical market has been segmented into following categories, in addition to the industry trends which have also been detailed below:UAE Pharmaceutical Market, by Drug Type:
- Generic Drugs
- Branded Drugs
UAE Pharmaceutical Market, by Product Type:
- Prescription Drugs
- Over the Counter Drugs
UAE Pharmaceutical Market, by Application:
- Cardiovascular
- Musculoskeletal
- Oncology
- Anti-infective
- Metabolic Disorder
- Others
UAE Pharmaceutical Market, by Distribution Channel:
- Retail Pharmacy
- Hospital Pharmacy
- E-Pharmacy
UAE Pharmaceutical Market, by Region:
- Dubai Region
- Sharjah Region
- Abu Dhabi Region
- Rest of UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in UAE pharmaceutical market.Available Customizations
The following customization options are available for the report:- Detailed analysis and profiling of additional market players (up to five).
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Julphar Gulf Pharmaceutical Industries
- Bayer Consumer Health
- Lifepharma FZE
- Niner Pharmaceuticals LLC
- GlaxoSmithKline & Neopharma
- Pfizer UAE
- Johnson & Johnson Middle East FZ-LLC
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 78 |
Published | August 2023 |
Forecast Period | 2022 - 2028 |
Estimated Market Value ( USD | $ 4009.31 Million |
Forecasted Market Value ( USD | $ 6436.59 Million |
Compound Annual Growth Rate | 7.9% |
Regions Covered | United Arab Emirates |